Methotrexate vs Sars-Cov-2 Virus Spike Protein
Methotrexate vs Sars-Cov-2 Virus Spike Protein: Overview
This comparison examines the pharmacological differences between Methotrexate and Sars-Cov-2 Virus Spike Protein.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5.
Molecular Weight: Methotrexate — 454.4400 g/mol.
Type: Methotrexate — Small molecule; Sars-Cov-2 Virus Spike Protein — Vaccine component.